#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Renal transplant Postprandial hypoglycaemia Mantle cell lymphoma VEXAS syndrome Pyoderma gangrenosum Acquired ATTR amyloidosis Glycogen storage disease type II Testicular leiomyosarcoma Biliary cancer metastatic Amyloidosis Glomerulonephritis chronic Anal cancer recurrent Non-renal cell carcinoma of kidney Congenital pseudarthrosis Infantile apnoea More trials…

    Learn about Rare Diseases

    Andersen-Tawil syndrome – Trials in Disease Mastocytosis – Trials in Disease Mucopolysaccharidosis II – Basic Information Pelizaeus-Merzbacher disease – Treatment Angiosarcoma non-metastatic – Basic Information Hairy cell leukaemia recurrent – Trials in Disease Encephalitis autoimmune – Diagnostics Alveolar rhabdomyosarcoma – Treatment Splenic marginal zone lymphoma – Treatment Prolymphocytic leukaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Methylphenidate Hydrochloride PRT3789 Rp1 GVV858 Bi 3720931 Metolazone Vindesine Sulfate Exemestane HUMAN THROMBIN Interferon Gamma Gfh925 Atl001 Paroxetine Dexamethasone Acetate Cipepofol Ep0031 Pegvaliase Censavudine Bupivacaine Hydrochloride Abelacimab More therapies…

    Learn about Your Condition

    Osteochondrodysplasia Duchenne muscular dystrophy Alagille syndrome Aphthous ulcer Hand dermatitis Malignant mast cell neoplasm Nephropathy Fibrosarcoma Cardiac disorder Renal impairment Pancreatitis acute Tertiary adrenal insufficiency Skin papilloma Tetanus Organ donor More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hippokrateslaan 10, Batiment 54, Woluwe-Saint-Lambert, 1200, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Ustekinumab for Children with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ustekinumab
    Belgium Germany Hungary Poland

  • Study on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Sar442970
    Belgium Czechia Denmark France Germany Greece +5

  • Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis

    Not recruiting

    3 1
    Investigated Drugs:
    • Ruxolitinib
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on Shortening Antibiotic Treatment for Febrile Neutropenia in Hematology Patients Using Cefepime and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Febrile neutropenia
    Investigated Drugs:
    • Cefepime
    • Ceftazidime
    • Imipenem
    Belgium

  • Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Favezelimab
    • Mk-4830
    • Quavonlimab
    Belgium Denmark Estonia France Germany Greece +7

  • Study on Long-term Safety of Apremilast in Children Aged 6-17 with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Belgium Czechia Italy Spain

  • Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Patritumab Deruxtecan
    • Carboplatin
    • Cisplatin
    Austria Belgium France Germany Italy The Netherlands +4

  • Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

    Not recruiting

    3 1
    Investigated Drugs:
    • Rocatinlimab
    Austria Belgium Finland France Germany Greece +9

  • Study of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • Pf-07220060 Monohydrate
    • Letrozole
    Belgium France Germany Italy Poland Slovakia +2

  • Long-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Elexacaftor
    • Tezacaftor
    • Ivacaftor
    Austria Belgium Czechia France Germany Hungary +7
Previous Page
1 … 63 64 65 66 67
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!